The invention relates to an antibody, a fragment or a derivative thereof, for use as an antiretroviral drug targeting a virus belonging to human endogenous retroviruses (HERV), wherein said antibody, fragment or derivative thereof is directed against HERV-W Envelope protein (HERV-W Env).